16 May 2019
Strong fundamentals underpin future growth
The wider use of proton therapy ("PT") has been limited by price, ease of use and installation hurdles in the past. AVO is on the cusp of disrupting the radiotherapy market as a whole supported by proven clinical superiority of PT combined with the implied economic advantages associated with linear accelerators. With the recently announced ISO certification de-risking regulatory approval and the appointment of Moataz Karmalawy paving the way for successful commercialisation, AVO has reached an i ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong fundamentals underpin future growth
Advanced Oncotherapy Plc (AVO:LON) | 1.9 0 0.0% | Mkt Cap: 10.4m
- Published:
16 May 2019 -
Author:
Martin Piehlmeier -
Pages:
22
The wider use of proton therapy ("PT") has been limited by price, ease of use and installation hurdles in the past. AVO is on the cusp of disrupting the radiotherapy market as a whole supported by proven clinical superiority of PT combined with the implied economic advantages associated with linear accelerators. With the recently announced ISO certification de-risking regulatory approval and the appointment of Moataz Karmalawy paving the way for successful commercialisation, AVO has reached an i ....